Evidence map›Paper›PMID 15345099›Full record

Trial reportBMC pediatrics2004

Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: a randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048].

Eduardo Salazar-Lindo, Percy Miranda-Langschwager, Miguel Campos-Sanchez, Elsa Chea-Woo, R Bradley Sack

Open access · goldAbstract readClinical TrialComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC pediatrics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 5 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 5 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Probiotics for treating acute infectious diarrhoea.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Efficacy ofWorld journal of gastroenterology · 2019
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Probiotics for treating acute infectious diarrhoea.The Cochrane database of systematic reviews · 2010
    Pooled it
  6. ProbioticNutrients · 2019
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. ProbioticFrontiers in pediatrics · 2023
    Article
  12. Review
  13. The Effects of Commercially AvailableInfection and drug resistance · 2022
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Eduardo Salazar-LindoDepartment of Pediatrics, Cayetano Heredia Hospital, Lima, Peru. edsalaza@ec-red.com
Percy Miranda-Langschwager
Miguel Campos-Sanchez
Elsa Chea-Woo
R Bradley Sack
Hospital Nacional Cayetano Heredia · PEJohns Hopkins University · USUniversidad Peruana Cayetano Heredia · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdjuvant therapy to ORT with probiotic bacteria for infants with acute watery diarrhea has been under active investigation. Most studies have been done in the developed world showing benefit only for viral mild gastroenteritis. We evaluated the effect of a milk formula containing one billion (109) cfu/ml of Lactobacillus casei strain GG (LGG) upon duration and severity of diarrhea in infants in an environment with more severe acute diarrhea, where etiologic agents other than rotavirus are involved more frequently, and where mixed infections are more prevalent.

methodsMale infants aged 3-36 months brought for treatment of acute watery diarrhea of less than 48 hours were eligible. After rehydration was completed with the WHO's oral rehydration solution, patients were randomly assigned to receive a milk formula either containing LGG or not. Stool volume was periodically measured using a devise suited to collect stools separate from urine. Duration of diarrhea was estimated based on stools physical characteristics.

resultsEighty nine patients received the placebo milk formula and ninety received the LGG containing formula. Both groups were comparable in their baseline characteristics. Total stool output was significantly larger (p = 0.047) in the LGG group (247.8 ml/kg) than in the placebo group (195.0 ml/kg). No significant differences were found in duration of diarrhea (58.5 hours with LGG vs. 50.4 hours with placebo), rate of treatment failure (21.1% with LGG vs. 18.0% with placebo), and proportion of patients with unresolved diarrhea after 120 hours (12.2% with LGG vs. 12.5% with placebo). The rate of stools with reducing substances after 24 hours of treatment increased significantly in both groups (from 41.4% to 72.2% with LGG and from 45.9% to 68.0% with placebo).

conclusionThis study did not show a positive effect of LGG on the clinical course of acute watery diarrhea. Positive beneficial effects of LGG, as had been reported elsewhere, could have been masked in our study by worsening diarrhea due to transient lactose malabsorption. Further studies with low-lactose or non-lactose conveyors of LGG are desirable.

Indexed as

Lacticaseibacillus caseiAcute DiseaseChild, PreschoolCombined Modality TherapyDiarrhea, InfantileDiuresisDouble-Blind MethodFecesFluid TherapyHumansInfantInfant FoodInfant FormulaMaleProbioticsTreatment Failure

Identifiers

PMID15345099
PMCPMC517719
OpenAlexW2120060765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.